Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Cogent Biosciences Inc (COGT)

304 + Investors. Track Smart Money conviction in COGT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +38
Streak
3Q ▲
Buyers last Q
62%

Smart Money Signals — COGT

Based on 305 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added COGT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
305 hedge funds hold COGT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +68% more funds vs a year ago

fund count last 6Q
+123 new funds entered over the past year (+68% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 62% buying

198 buying123 selling
Last quarter: 198 funds were net buyers (77 opened a brand new position + 121 added to an existing one). Only 123 were sellers (84 trimmed + 39 sold completely). A clear majority buying is a strong confirmation signal.
⚠️

Fewer new buyers each quarter (-19 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 30 → 40 → 96 → 77. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
📌

Mixed — 38% long-term, 37% new

■ 38% conviction (2yr+) ■ 25% medium ■ 37% new
Of the 305 current holders: 116 (38%) held >2 years, 75 held 1–2 years, and 114 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
🚀

Acceleration phase — new buyers rushing in

34 → 30 → 40 → 96 → 77 new funds/Q
New funds entering each quarter: 30 → 40 → 96 → 77. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 50% veterans vs 40% newcomers

■ 50% veterans ■ 10% 1-2yr ■ 40% new
Entry-cohort mix of 315 holders: 157 (50%) are 2+ year veterans, 33 entered 1–2 years ago, and 125 (40%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 35% AUM from major funds

35% from top-100 AUM funds
51 of 303 holders rank in the top 100 by AUM, accounting for 35% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
5.0
out of 10
Moderate Exit Risk
Exit risk score 5.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — COGT

In 2026 Q1, 198 hedge funds were net buyers of COGT (77 opened a new position, 121 added to an existing one), while 123 reduced or exited (84 trimmed, 39 sold completely) — a 62% buyer ratio, indicating clear institutional accumulation. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 35% of total institutional value in COGT is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +38 funds (more new holders than closures). Total institutional holders: 305.

Hedge Fund Ownership: COGT

How many hedge funds hold COGT — quarterly history vs. share price
Quarterly hedge fund ownership of COGT vs. share price

Market Analysis: COGT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: COGT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Cogent Biosciences Inc (COGT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much COGT has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 75d ago
COGT
-14.0%
XLV
+4.9%

COGT outperformed XLV by -18.9% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 30d ago
COGT
+1.3%
XLV
+6.0%

Since the filing became public, COGT outperformed XLV by -4.7% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Growing Institutional Interest

Quality funds are building positions — conviction is rising but not yet widespread.

29 top-rated funds 14 high-conviction
Consensus
6.4
/ 10
breadth
×
Elite
6.5
/ 10
conviction
Hedge Fund Positioning: COGT
304 + Investors

Track Smart Money conviction in COGT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 304 267 13.86%
13F Shares 187M 175M 7.14%
Total Value $6.94B $6.12B 13.5%
New Positions 76 96 -20
Increased Positions 119 91 +28
Closed Positions 39 20 +19
Reduced Positions 81 65 +16
Total Calls 6 5 20.0%
Total Puts 6 3 100.0%
PUT/CALL Ratio 1.0 0.6 Neutral

Statistics: COGT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

304 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in COGT. Verified SEC 13F-HR filings.

QUARTER:
Top 25 COGT holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Fairmount Funds Management LLC 15.30% 5,503,418 $211.8M
2 Elmind Capital, LP 12.79% 1,170,740 $45.1M
3 Squadron Capital Management LLC 11.11% 787,492 $30.3M
4 Octagon Capital Advisors LP 10.01% 2,350,000 $90.5M
5 Kynam Capital Management, LP 9.59% 4,037,331 $155.4M
6 Commodore Capital LP 6.43% 2,888,007 $111.2M
7 Superstring Capital Management LP 6.19% 225,158 $8.7M
8 Exome Asset Management LLC 5.54% 278,533 $10.7M
9 TCG Crossover Management, LLC 5.45% 4,946,894 $190.4M
10 Silverarc Capital Management, LLC 5.16% 1,314,189 $50.6M
11 Saturn V Capital Management LP 4.37% 626,635 $24.1M
12 Deerfield Management Company, L.P. 4.11% 9,043,903 $348.1M
13 First Turn Management, LLC 4.07% 947,339 $36.5M
14 Patient Square Capital LP 4.07% 596,000 $22.9M
15 Sofinnova Investments, Inc. 3.09% 2,113,551 $81.4M
16 Venrock Adviser, LLC 2.87% 2,000,000 $77.0M
17 Sphera Funds Management LTD. 2.54% 416,340 $16.0M
18 Knott David M Jr 2.38% 104,000 $4.0M
19 NEXTBio Capital Management LP 2.34% 131,188 $5.0M
20 Diadema Partners LP 2.11% 322,764 $12.4M
21 HighVista Strategies LLC 2.09% 197,051 $7.6M
22 Rtw Investments, LP 2.09% 5,458,675 $210.1M
23 Emerald Advisers, LLC 1.93% 1,588,132 $61.1M
24 Emerald Mutual Fund Advisers Trust 1.92% 1,028,832 $39.6M
25 Defilade Capital Management, L.P. 1.91% 352,590 $13.6M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Cogent Biosciences Inc (COGT)

What does the Smart Money Trend signal show for COGT?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added COGT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for COGT?

More buyers than sellers — 62% buying: Last quarter: 198 funds were net buyers (77 opened a brand new position + 121 added to an existing one). Only 123 were sellers (84 trimmed + 39 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for COGT holders?

Strong quality — 35% AUM from major funds: 51 of 303 holders rank in the top 100 by AUM, accounting for 35% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held COGT?

Mixed — 38% long-term, 37% new: Of the 305 current holders: 116 (38%) held >2 years, 75 held 1–2 years, and 114 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Cogent Biosciences Inc (COGT) following the 2026 Q1 hedge fund 13F filings?

As of today, COGT has moved +1.3% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -4.7%. Since the quarter end (March 31, 2026), COGT has gained -14.0% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →